Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink

BACKGROUND: Intensification of metformin monotherapy with additional glucose-lowering drugs is often required in patients with type 2 diabetes (T2D). This study evaluated changes in HbA1c and weight, as well as treatment persistence, associated with different second-line therapies used in UK clinica...

Full description

Saved in:
Bibliographic Details
Published in:BMC Med
Main Authors: Wilding, John, Godec, Thomas, Khunti, Kamlesh, Pocock, Stuart, Fox, Robin, Smeeth, Liam, Clauson, Per, Fenici, Peter, Hammar, Niklas, Medina, Jesús
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047134/
https://ncbi.nlm.nih.gov/pubmed/30008267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1085-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items